TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Rohto Pharmaceutical Co ( (JP:4527) ) just unveiled an announcement.
Rohto Pharmaceutical Co., Ltd. announced a resolution to pay dividends from retained earnings, with a record date of March 31, 2025. The year-end dividend per share is set at 20 yen, consistent with the most recent forecast, and represents an increase from the previous fiscal year’s 15 yen per share. This decision reflects the company’s strong financial performance and commitment to returning value to shareholders, potentially enhancing its market position and investor confidence.
The most recent analyst rating on (JP:4527) stock is a Buy with a Yen4770.00 price target. To see the full list of analyst forecasts on Rohto Pharmaceutical Co stock, see the JP:4527 Stock Forecast page.
More about Rohto Pharmaceutical Co
Rohto Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of healthcare and skincare products. The company is known for its innovative solutions in over-the-counter medicines and cosmetics, catering to a global market.
YTD Price Performance: -25.44%
Average Trading Volume: 1,432,605
Technical Sentiment Signal: Sell
Current Market Cap: Yen493.8B
See more insights into 4527 stock on TipRanks’ Stock Analysis page.